CSF1R and neoplasm: TLR agonists have been identified as potent immunostimulatory molecules capable of inducing M1 macrophage repolarization [37], while the CSF1/CSF1-R signaling pathway between tumor cells and macrophages is responsible for the phenotypic transition to immunosuppressive M2 phenotype [38].